In The News
Judge who acted in ‘hot contest’ shouldn’t hear Greensill case, court told
ASIC, Noumi privilege win gives comfort to companies mulling VDAs
Cantarella loses bid to revive ‘Oro’ trade mark
Seven, reporter win strike-out bid in AFL player’s defamation case
Spat over Fonterra’s Australian departure lands Bega in court
Epiroc resolves feud with Rio Tinto unit over drilling patent
Clayton Utz snags EY risk advisory pro
Carnival wins approval of settlement in P&O ‘cruise from hell’ class action
AAI class action trial delayed as firm waits for $1.7M bank guarantee
Court invalidates Otsuka’s patent for injectable Abilify
Please login to bookmark Close

The Therapeutic Goods Administration is seeking feedback on its proposed process for handling advertising complaints when stricter new advertising rules for therapeutic products take effect later this year. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au